Small biopharma companies often need to partner with larger firms to achieve their goals. Here, Diane Seimetz and Jörg Schneider discuss how due diligence smooths the path to collaboration.

Discover the opportunities Altasciences' hybrid approach to project management can offer your drug development programme.

A unique partnership, the Access to Oncology Medicines (ATOM) Coalition, has been established to ensure sustainable access to cancer medicines in low- and lower middle-income countries (LLMICs) in the long-term.

US Government investigation report suggests Emergent Biosolutions destroyed almost 400 million doses of COVID-19 vaccine and worked to conceal quality issues from the FDA.

AstraZeneca has entered into a licence agreement with RQ Biotechnology Ltd for a portfolio of early-stage monoclonal antibodies (mAbs) targeted against SARS-CoV-2.